Möchten Sie immer auf dem neuesten Stand bleiben?

Facility expected to be operational in 2028 in Dallas-Fort Worth area, expanding largest RLT manufacturing network in USSite to serve patients in Southern US and add network capacity as RLT expands...

Facility expected to be operational in 2028 in Dallas-Fort Worth area, expanding largest RLT manufacturing network in USSite to serve patients in Southern US and add network capacity as RLT expands...

In the real-world, Pluvicto™ showed 13.5 months median PFS in chemo-naïve patients with PSMA-positive mCRPCReal‑world evidence showed Pluvicto achieved longer PFS when initiated after one ARPI instead...

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including Cambridge, Massachusetts, and Basel,...

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including Cambridge, Massachusetts, and Basel,...

Dublin, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The "Cell-Based Assay & High Content Screening Market 2025-2029 - Forecasts by User and Product, with Executive and Consultant Guides" report has been...

Vail, Colorado, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Steadman Philippon Research Institute (SPRI) and Vail Health have renewed their longstanding partnership with a new five-year agreement advancing...

New York, Jan. 27, 2026 (GLOBE NEWSWIRE) -- A pivotal scientific collaboration born out of the Muscular Dystrophy Association’s (MDA) Muscle Regeneration Summit is advancing a first-of-its-kind...

New York, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today that John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), will...

Dublin, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The "North America Mass Spectrometry Market Report by Product, Technology, End Use, Application, Countries and Company Analysis, 2025-2033" report has been...